Evidence map›Paper›PMID 27647668›Full record

ArticleJournal of biomolecular screening2016

One-Step Seeding of Neural Stem Cells with Vitronectin-Supplemented Medium for High-Throughput Screening Assays.

Sheng Dai, Rong Li, Yan Long, Steve Titus, Jinghua Zhao, Ruili Huang, Menghang Xia, Wei Zheng

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomolecular screening, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sheng Dai1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Rong Li1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Yan Long1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Steve Titus1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Jinghua Zhao1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Ruili Huang1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Menghang Xia1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Wei Zheng1 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
National Institutes of Health · USNational Center for Advancing Translational Sciences · US

Funding

Small molecule screening programZ01HG200319 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI AUSTIN, CHRISTOPHER P · 2004 to 2008
$32.3M
Drug Repurposing Screening for Rare and Neglected DiseasesZIATR000018 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI ZHENG, WEI · 2015 to 2025
$24.6M
Intramural NIH HHS Z01 HG200319Intramural NIH HHS ZIA TR000018
6 · The paper itself

Abstract

Human neuronal cells differentiated from induced pluripotent cells have emerged as a new model system for the study of disease pathophysiology and evaluation of drug efficacy. Differentiated neuronal cells are more similar in genetics and biological content to human brain cells than other animal disease models. However, culture of neuronal cells in assay plates requires a labor-intensive procedure of plate precoating, hampering its applications in high-throughput screening (HTS). We developed a simplified method with one-step seeding of neural stem cells in assay plates by supplementing the medium with a recombinant human vitronectin (VTN), thus avoiding plate precoating. Robust results were obtained from cell viability, calcium response, and neurite outgrowth assays using this new method. Our data demonstrate that this approach greatly simplifies high-throughput assays using neuronal cells differentiated from human stem cells for translational research.

Indexed as

Cell Culture TechniquesCell DifferentiationCulture MediaHigh-Throughput Screening AssaysHumansInduced Pluripotent Stem CellsNeural Stem CellsVitronectinCulture MediaVitronectinhigh-content screeninghigh-throughput screeningHTSinduced pluripotent stem cellsiPSCneural stem cellsneuronal cellsplate coatingvitronectin

Identifiers

PMID27647668
PMCPMC5285267
OpenAlexW2521159977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.